Nuvalent Strengthens Board of Directors with Christy Oliger's Appointment Nuvalent, a biopharmaceutical company, welcomes Christy Oliger to its Board, enhancing its focus on targeted cancer therapies and upcoming innovations.

Nuvalent Strengthens Board of Directors with Christy Oliger's Appointment #United_States #biopharmaceuticals #Cambridge #Nuvalent #Christy_Oliger